Announcements Trials

Browse Landscape

Phase

Status

Completed 17 Recruiting 3 Unknown 2 Terminated 2 Not yet recruiting 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1

Interventions

pembrolizumab 439 Carboplatin 322 Nivolumab 298 Cyclophosphamide 286 Specimen Handling 271 Magnetic Resonance Spectroscopy 259 Cisplatin 250 Paclitaxel 249 Radiotherapy 230 Dexamethasone 184 Biopsy 182 Gemcitabine 180 durvalumab 171 atezolizumab 152 Doxorubicin 141 Rituximab 138 Lenalidomide 136 Ipilimumab 134 Docetaxel 132 Bevacizumab 132 Radiation 121 Capecitabine 120 Oxaliplatin 116 Etoposide 116 Radiosurgery 113 Fluorouracil 112 Pemetrexed 109 fludarabine 106 venetoclax 102 Prednisone 97

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Dosage Forms × Clear all

NCT05309668 2025-12-18

SPRINKLE

AstraZeneca

Phase 1/2 Active not recruiting

36 enrolled 37 charts

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡